MAN-19

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameMAN-19

Drug Alias NameMAN-19

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionTEK receptor tyrosine kinase agonists

TargetsTEK receptor tyrosine kinase

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMannin Research Inc

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

ATC CodeN/A